 hits acquisition trail swiss announced purchases make unit world biggest generic drug producer month forecast record sales bought acquired 67.7 affiliate eon labs offered buy remaining shares able make cost savings following acquisitions shares rose 57.85 swiss francs early trading deal business overtake pharmaceuticals world biggest maker generics based figures newly merged producer sales company estimated merge number departments adding job cuts strong growth outlook create jobs expected partially compensate necessary reductions work force firm statement generic drugs chemically identical expensive branded rivals producers copy branded products usually patent protection expires sell cheaply pay research development cost generic worldwide analysts predicted consolidation market fragmented analysts initially convinced deal expensive acquisition investment bank told strange making acquisitions exactly markets suffered price pressure